Market Overview

UPDATE: Jefferies Initiates Coverage on Prestige Brands on Expected Competitive Headwinds

Share:
Related PBH
Top 4 Stocks In The Medical Equipment Wholesale Industry With The Highest Gross Margin
Cardinal Health Purchases The Harvard Drug Group For $1.115 Billion

In a report published Tuesday, Jefferies analyst Kevin Grundy initiated coverage on Prestige Brands Holdings (NYSE: PBH) with a Hold rating and $36.00 price target.

In the report, Jefferies noted, “We are initiating coverage of PBH with a Hold rating and $36 price target. Through transformative M&A, PBH is now uniquely positioned as a pure-play in the attractive (and consolidating) OTC industry. However, the stock has significantly re-rated over the LTM and we expect PBH to face meaningful competitive headwinds in the near-term, which should provide investors with a better entry point into an attractive long-term story.”

Prestige Brands Holdings closed on Monday at $33.26.

Latest Ratings for PBH

DateFirmActionFromTo
Aug 2015JefferiesMaintainsHold
Feb 2015Raymond JamesDowngradesOutperformMarket Perform
Jan 2015JefferiesMaintainsHold

View More Analyst Ratings for PBH
View the Latest Analyst Ratings

Posted-In: Jefferies Kevin GrundyAnalyst Color Initiation Analyst Ratings

 

Related Articles (PBH)

Get Benzinga's Newsletters